    Mudit Jain | Synergy Life Science Partners , LP | ZoomInfo.com


The Synergy Team
















































 



Mudit K. Jain, Ph.D.
Managing Director
Mudit K. Jain, PhD is a General Partner at Synergy Life Science Partners and brings nearly two decades of experience in various functional and leadership roles in research, product development, business development, M&A, and venture capital. Mudit's career has been focused on identifying, developing, and investing in new medical device technologies serving large unmet clinical needs. Mudit brings a global perspective to Healthcare based on his experiences in US and India.
At Synergy, Mudit is responsible for sourcing opportunities, conducting diligence, executing  transactions, serving on portfolio boards and fund administration, including but not limited to managing LP relationships and fund raising efforts.  Mudit serves or served as a member of the Board of Directors of Aptus Endosystems (Acqd by Medtronic), Inspire Medical Systems, Neuspera, Inc., and NeuroTronik Limited, and  is actively involved with  iRhythm Technologies, (NSDQ: IRTC). Two of Mudit's investments were listed in the FierceMedicalDevices' 2014 Fierce 15, a recognition of the most promising private medical device companies that embody a huge leap forward.
Most recently, Mudit was with Johnson and Johnson Development Corporation (JJDC) as part of their management team and focused on all aspects of medical devices and diagnostics venture investments.  Mudit led  JJDC's  medical device investments in the Midwest and East Coast with initial and follow-on  investments in multiple device companies including    CVRx, AngelMedical, GI Dynamics (ASX: GID), CardioMEMS (acqd: St. Jude Medical), and Impres Medical (acquired: Johnson and Johnson). Mudit also worked with Johnson and Jonson's medical device senior leadership on multiple strategic projects, and multi-billion dollar acquisitions. Prior to JJDC, Mudit was a Corporate Director with Corporate Office of Science and Technology at Johnson and Johnson. Before Johnson and Johnson, Mudit was with Guidant Corporation's Cardiac Rhythm Management Division and led the research and development of key technologies focused on cardiac ablation and cardiac resynchronization therapy. Mudit also played a key role in the early stage technology development for multiple venture backed medical device start-ups including Epicor, Inc. (acquired: St. Jude Medical), and Cardiac Pathways Corporation (acquired: Boston Scientific).  Mudit holds eight issued patents and has published numerous articles in peer reviewed publications. Prior to his experiences in medical devices, Mudit worked in operational roles in petrochemical industry in India.

Mudit served as Chair of TiE (The Indus Entrepreneur) Silicon Valley, one of the largest entrepreneur network in Silicon Valley, from 2012-2014 and currently serves on the John Hopkins University Coulter Program Oversight Board, and on the Board of Visitors at Duke University's Graduate School.

Mudit graduated with a B.E. in Electrical Engineering from Regional Engineering College, Nagpur, India (ranked first in his class). He received his Ph.D. in Biomedical Engineering from Duke University, and his M.B.A. from the Wharton School, University of Pennsylvania.

Contact Mudit K. Jain





Mudit K. Jain, Ph.D.
Richard Stack, M.D.
William (Bill) Starling
Tracy Pappas





 Cure Chamber












An example of a new device to be funded by Synergy is the photopolymerization curing chamber [short description] for [Company Name].
 






















Mudit K. Jain Ph.D.: Executive Profile & Biography - Bloomberg









































  





















































































July 29, 2017 3:52 AM ET
Capital Markets

Company Overview of Synergy Life Science Partners



SnapshotPeople 




OverviewBoard MembersCommittees



Executive Profile
Mudit K. Jain Ph.D.Partner, Synergy Life Science PartnersAgeTotal Calculated CompensationThis person is connected to 2 Board Members in 2 different organizations across 2 different industries.See Board Relationships----
Background

		Dr. Mudit K. Jain, Ph.D is a Partner of Synergy Life Science Partners. Dr. Jain has more than a decade of operational experience in various functional roles including research, product development, business development, M&A and venture capital. Dr. Jain was a Principal of Synergy Life Science Partners. Dr. Jain served as an Executive Director with Johnson and Johnson Development Corporation (JJDC) as part of their management team and led the it’s medical device investments ... in the Midwest and East Coast. Prior to JJDC, he served as Corporate Director with Corporate Office of Science and Technology at JNJ, where he worked with JNJ’s Chief Scientific Officer and was instrumental in evaluating and assessing early stage growth opportunities for the medical device franchises across JNJ. Prior to JNJ, Dr. Jain served with Guidant Corporation’s Cardiac Rhythm Management Division and led their efforts to develop and evaluate new medical device technologies in cardiac ablation, heart failure and regenerative therapies. He also worked as a Consultant to Epicor, Inc., Cardiac Pathways Corporation and Medtronic. Dr. Jain serves as a Director of Synecor, LLC and Inspire Medical Systems. He has been a Director of Aptus Endosystems, Inc. since June 2012. He serves as Board Observer for Oraya Therapeutics. He had board responsibilities for JJDC investments. Dr. Jain holds seven issued patents and has published numerous articles in peer reviewed publications. He has Ph.D. from Duke University in Biomedical Engineering. His was the first Ph.D. awarded in cardiac radiofrequency ablation in the nation. Dr. Jain graduated with a B.E. in Electrical Engineering from Regional Engineering College, Nagpur, India, where he ranked first in his class. Dr. Jain has an M.B.A. from the Wharton School in Healthcare Management and Finance and was named on the Director’s list for academic achievement.Read Full Background




Corporate Headquarters
P.O. Box 22489San Francisco, California 94122United StatesPhone: 650-854-7155Fax: 650-854-7156
Board Members Memberships
DirectorSynecor LLC2012-PresentDirectorAptus Endosystems, Inc.
Education
PhD Duke UniversityMBA University of Pennsylvania - The Wharton School
Other Affiliations
Synecor LLCDuke UniversityAptus Endosystems, Inc.University of Pennsylvania - The Wharton School


Annual Compensation
				There is no Annual Compensation data available.
				Stocks Options
				There is no Stock Options data available.
				Total Compensation
				There is no Total Compensation data available.
			



Request Profile Update
















 












The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking 
	here.




Stock Quotes


Market data is delayed at least 15 minutes.







Company Lookup



COMPETITOR COMPENSATIONThere is no Competitor Compensation data available.










Sponsored Financial Commentaries

Sponsored Links






Browse Companies
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
 | 
0
1
2
3
4
5
6
7
8
9






Request Profile Update

						Only a company representative may request an update for the company profile. Documentation will be required.
					  
To contact Synergy Life Science Partners, please visit .  Company data is provided by S&P Global Market Intelligence.  Please use this form to report any data issues.
					  


Information Missing - Please enter your information in the following field(s): 




Company Name

Your Name*

Your E-Mail Address*

Your Phone Number*

Type of Data*


Overview
Executives
Key developments
Similar companies
Transactions


Update Needed*

All data changes require verification from public sources.  Please include the correct value or values and a source where we can verify.


Cancel


Submit






Your requested update has been submitted
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.


Close





























Microsoft personalized ad preferences




 













To opt out of personalized ads in this browser, your browser history must allow first-party and third-party cookies and you must have your browsing experience set to NOT delete browsing history on exit. Instructions for enabling cookies and configuring your browsing history may be available in your browsers settings, privacy, or help documentation.

















Sign in
















  Hold on… We’re sorry but this didn’t work.                  You can’t turn off personalized ads right now because your browser is currently blocking third-party cookies. We can help you fix this issue.                Let’s get started:  Depending on what browser you use, open Options or Settings.                  Make sure that third-party cookies are not blocked anymore. To find out how, search your browser’s Help.                                 Revisit http://choice.microsoft.com/opt-out, and then on the “Personalized ads in this browser” tile, click Off.                 ext74081 




  About Our Ads To create a more customized online experience, some of the ads you may receive on Microsoft websites and apps are tailored to your previous activities, searches and site visits. You're in control and here's where you can make the advertising choice that's right for you. ext74075 




  Where Can I Learn More about Advertising on Microsoft Websites and Apps? Microsoft partners with Oath, AppNexus and other third party service providers to help present customized content and display advertisements on MSN, Outlook.com and other websites and apps. Microsoft also delivers search ads to Bing and our search syndication partners. Learn more about Microsoft’s privacy practices here. You can learn more about interest-based ads from Oath and AppNexus in their privacy statements: Oath and AppNexus. What Choices Do I Have About Interest-Based Advertising? On this page, you can opt out of receiving interest based advertising from Microsoft. You can also opt out of receiving interest-based advertising from all self-regulatory members, including Microsoft, Oath, AppNexus and other third party ad networks, at the following sites:  In the US: Digital Advertising Alliance (DAA) In Europe: European Interactive Digital Advertising Alliance (EDAA) In Canada: Ad Choices: Digital Advertising Alliance of Canada (DAAC)  You can control interest-based advertising in Windows apps by turning off the advertising ID in Windows Settings.  More choices  Do you want personalized ads from other companies?  Questions? If you have a privacy question or a question for the Chief Privacy Officer of Microsoft, please contact us by using our web form. We will respond to questions within 30 days. ext74076 




       Personalized ads in this browser     OFF    Opt-out is currently unavailable, please try again later.  Control the "personalized ads" setting for this web browser.  Learn more           If you want Microsoft to show ads that might be relevant to you, click On. To show “generic” ads, click Off.          ext74078 




       Personalized ads wherever I use my Microsoft account     OFF   Sign in to change...    Opt-out is currently unavailable, please try again later.  Control the "personalized ads" setting that applies when you are signed in on any computer or device with your Microsoft account, including Windows, Windows phone, Xbox and other devices.  Learn more                    If you want Microsoft to show ads that might be relevant to you, click On. To show “generic” ads, click Off.         If you choose “generic” ads and use a browser, your choice applies to everyone when using that browser as long as you do not clear your cookies.          ext74079 




       Personalized ads in Windows         In your Windows Settings, you can turn off personalized ads that appear in apps on this device. You’ll still see ads, but they won’t be personalized anymore.     If you have Windows 8.1:            Access the charms by touching or moving your pointer to the right edge of the screen.                 Click or tap Settings, and then click or tap Change PC Settings.                 Click or tap Privacy, and then turn off Let apps use my advertising ID for experiences across apps.          If you have Windows 10:            Click or tap the Start button.                 Click or tap Settings.                 Click or tap Privacy, and then turn off Let apps use my advertising ID for experiences across apps.          If you have a Windows mobile device:            Go to Settings.                 Tap on Privacy.                 Tap on Advertising ID, and then turn off Let apps use my advertising ID for experiences across apps.                If you want to turn off personalized ads from Microsoft wherever you use your Microsoft account including apps on Windows, Windows Phone, Xbox and other devices, you can do so by selecting the Microsoft account option above.    ext74080 














Legal
Privacy & Cookies
© 2017 Microsoft









 












Mudit K. Jain | Drupal









































Skip to main content
Skip to navigation











 


Home
About TiE
Pricing
Venue/Travel
 
 




 


 
 


You are here Mudit K. Jain 

Share : 






 
 

Managing DirectorSynergy Life Science Partners Mudit K. Jain, PhD is a Managing Director at Synergy Life Science Partners and brings nearly two decades of experience in various functional roles including research, product development, business development, M&A, and venture capital. Mudit currently serves as a member on the Board of Directors of Inspire Medical Systems, Aptus Endosystems, and NeuroTronik Limited, and is actively involved with other Synergy portfolio companies - iRhythm Technologies, and TransEnterix, Inc. (NYSE: TRXC). Three of Mudit’s investments were listed in the FierceMedicalDevices’ 2014 Fierce 15, a recognition of the most promising private medical device companies that embody a huge leap forward.
Prior to Synergy, Mudit was with Johnson and Johnson Development Corporation (JJDC) as part of their management team and focused on all aspects of medical device venture investments. Mudit led JJDC’s medical device investments in the Midwest and East Coast with initial and follow-on investments in multiple device companies including Direct Flow Medical, GI Dynamics (ASX: GID), CardioMEMS (acquired: St. Jude Medical), and Impres Medical (acquired: Johnson and Johnson). Mudit also worked with JNJ’s medical device senior leadership on multiple strategic projects, and multi-billion dollar acquisitions. Prior to JJDC, Mudit was a Corporate Director with Corporate Office of Science and Technology at Johnson and Johnson. Before Johnson and Johnson, Mudit worked at Guidant Corporation's Cardiac Rhythm Management Division and led the research and development of key technologies focused on cardiac ablation for atrial fibrillation and cardiac resynchronization therapy for heart failure. Mudit also played a key role in the early stage technology development for multiple venture backed medical device start-ups including Epicor, Inc. (acquired: St. Jude Medical), and Cardiac Pathways Corporation (acquired: Boston Scientific).
Mudit graduated with a B.E. in Electrical Engineering from Regional Engineering College, Nagpur, India (ranked first in his class). He received his Ph.D. in Biomedical Engineering from Duke University, and his M.B.A. from the Wharton School, University of Pennsylvania.
 





Moderator for 





            Title          

            Time          





Medical Devices - a changing landscape 

            Saturday, May 16th  02:30 pm to 03:00 pm 




 
 
 




 
pornomier.xyzpornogalinholatürk sikiş‏pornopintinhopornoovelhapornopinguimpornolobopornofrangosu tesisatçısısessocanarinosessogattino

 
 


Tweets by @TiEcon 
 
 





 

Recent blog posts



  
 TiEcon 2015 Cares about Nepal - Donate and #TiEcon will Match Dollar for Dollar up to $25K 
  
*/

 
Diversifying the Entrepreneurial Ecosystem
No Limitation to Outreach and Caring for our Glob... 

 Ready, Set, Prepare to Break Away Disruptive Entrepreneurs - #TiEcon 2015 Maximizing Your Experience 
  

Maximizing TiEcon Entrepreneurs' "Burning Man" Experience 


We are amped up to kick-start an ele... 

 Programming to Learn 
  It’s widely acknowledged that teaching children to code early in life is a good idea. Programming i... 
 

View All 
 
 


 

 
 


Register Now






Mudit K.  Jain - CEO, founder, businessman - profile

















directorpedia.net - List of CEOs, founders, board members and company directors











Mudit K.  Jain
Check out list of companies and businesses related to Mudit K.  Jain. Find out Mudit K.  Jain address and contact details. View other people related to Mudit K.  Jain - coworkers, colleagues, companions, etc.
Address:   

3284 ALPINE ROAD  PORTOLA VALLEY 94028 CA




Companies related to Mudit K.  Jain
CIKCompany NamePositionCompany Address0000876378TRANSENTERIX INC.635 DAVIS DRIVE SUITE 300 MORRISVILLE 275600001388658iRhythm Technologies, Inc.650 TOWNSEND STREET SUITE 380 San Francisco 94103




Mudit K.  Jain on the Web
Persons related to Mudit K.  Jain - TRANSENTERIX INC.NamePositionCityJackson  AdamMiamiKherani, M.D.  AftabMiamiKherani  AftabMorrisvilleAISLING CAPITAL III LPNEW YORKAISLING CAPITAL III LP10% Owner NEW YORKAISLING CAPITAL III LP10% Owner NEW YORKAisling Capital Partners III LLCNEW YORKAisling Capital Partners III LLCNEW YORKAisling Capital Partners III LLCNEW YORKAisling Capital Partners III LPNEW YORKAisling Capital Partners III LPNEW YORKAisling Capital Partners III LPNEW YORKBiffi  AndreaMorrisvilleJOSHUA J  ANGELDirector SEATTLEJOSHUA J  ANGELDirector NEW YORKFernando  AnthonyMorrisvilleBARRY J  BEILDirector SEATTLEAndrea  BiffiDirector TREZZANO ROSAKenneth  BlockChief Financial Officer VALLEY STREAMChen  ChaoMiamiChen  ChaoMiamiFilipi  CharlesMiamiFilipi  CharlesMiamiFilipi, M.D.  CharlesMiamiChao C  ChenTAIPEIChao C  ChenDirector MIAMIMilne  DavidMiamiMilne  DavidMorrisvilleStewart B  DavisCOO & Secretary MIAMIStewart B  DavisCOO MIAMIStewart B  DavisCOO MIAMIDougherty  DennisMiamiDennis  DoughertyDirector DURHAMDennis  DoughertyDirector DURHAMSTEVE  ELMSCHESTERSTEVE  ELMSNEW YORKSTEVE  ELMSNEW YORKSTEVE  ELMSNEW YORKAnthony C. J.  FernandoChief Operating Officer MORRISVILLECharles  FilipiOMAHACharles  FilipiDirector MIAMICharles  FilipiChief Medical Officer MIAMIFrost Gamma Investment TrustMIAMIFrost Gamma Investment TrustMIAMIFrost Gamma Investment TrustMIAMIFrost Gamma Investment TrustMIAMIFrost Gamma Investments TrustMIAMIFrost Gamma Investments TrustMIAMIFrost Gamma Investments TrustMIAMIFrost Gamma Investments TrustMIAMIPHILLIP MD ET AL  FROST10% Owner MIAMIPHILLIP MD ET AL  FROST10% Owner MIAMIPHILLIP MD ET AL  FROST10% Owner MIAMIPHILLIP MD ET AL  FROSTMIAMIKenneth  HeithoffDirector MINNEAPOLISKenneth  HeithoffDirector FISHER ISLANDJANE PH D  HSIAODirector JANE PH D  HSIAODirector MIAMIJANE PH D  HSIAODirector MIAMIJANE PH D  HSIAOMIAMIJANE PH D  HSIAODirector MIAMIAdam S  JacksonMIAMIAdam S  JacksonCFO MIAMIAdam S  JacksonChief Financial Officer MIAMIMudit K.  JainPORTOLA VALLEYMartin  JamesMiamiMartin  JamesMiamiMartin  JamesMiamiHsiao  JaneMiamiHsiao  JaneMiamiHsiao  JaneMorrisvilleHsiao, Ph.D.  JaneMiamiSpragens  JeffreyMiamiSpragens  JeffreyMiamiSlattery  JosephMorrisvilleSTEPHEN  KATZChief Executive Officer SEATTLESTEPHEN  KATZChief Executive Officer VALLEY STREAMWILLAM N  KELLEYDirector WILLAM N  KELLEYDirector MORRISVILLEWayne  KevinMiamiWayne  KevinMiamiAftab  KheraniDirector NEW YORKPAUL A  LAVIOLETTEDirector NATICKPAUL A  LAVIOLETTEDirector BOSTONJames Joseph  MartinChief Financial Officer MIAMIDavid Bruce  MilneDirector BOSTONDavid Bruce  Milne10% Owner BOSTONRichard  MuellerMIAMIRichard  MuellerChief Operating Officer MORRISVILLELaViolette  PaulMiamiLaViolette  PaulMorrisvilleRICHARD C  PFENNIGER JRDirector MIAMIRICHARD C  PFENNIGER JRDirector MIAMIRICHARD C  PFENNIGER JRDirector MIAMIRICHARD C  PFENNIGER JRDirector MORRISVILLERICHARD C  PFENNIGER JRMIAMIRICHARD C  PFENNIGER JRDirector MIAMIFrost, M.D.  PhillipMiamiTodd  PopePresident and CEO MIAMITodd  PopePresident and CEO MORRISVILLEDennis J  PurcellNEW YORKDennis J  PurcellNEW YORKDennis J  PurcellNEW YORKPfenniger, Jr.  RichardMiamiPfenniger, Jr.  RichardMiamiPfenniger, Jr.  RichardMiamiJr.  Pfenniger  Richard,MorrisvilleMueller  RichardMiamiSteven D  RubinDirector MIAMISteven D  RubinDirector MIAMISteven D  RubinMIAMISteven D  RubinDirector MIAMIANDREW N  SCHIFFNEW YORKANDREW N  SCHIFFNEW YORKDR DREW  SCHIFFNEW YORKLAWRENCE  SCHOENBERGDirector SEATTLEJOSEPH P  SLATTERYEVP and CFO JOSEPH P  SLATTERYEVP and CFO MORRISVILLES.p.A  SOFAR,10% Owner TREZZANO ROSAJeffrey G  SpragensPresident and CEO MIAMIJeffrey G  SpragensPresident and CEO MIAMIJeffrey G  SpragensPresident and CEO MIAMIJeffrey G  SpragensCEO MIAMIJeffrey G  SpragensPresident and CEO MIAMIJeffrey G  SpragensPresident and CEO MIAMIRichard S.  Stack10% Owner PORTOLA VALLEYWilliam N  Starling JRDirector POCATELLOWilliam N  Starling JRDirector PORTOLA VALLEYWilliam N  Starling JRDirector PORTOLA VALLEYStepStone Group Holdings LLC10% Owner NEW YORKStepStone Group Holdings LLCNEW YORKStepStone Group LPSAN DIEGOStepStone PC GP, LLCNEW YORKStepStone PC GP, LLCNEW YORKStepStone Pioneer Capital Buyout Fund II, L.P.NEW YORKStepStone Pioneer Capital Buyout Fund II, L.P.NEW YORKStepStone Pioneer Capital II, L.P.NEW YORKStepStone Pioneer Capital II, L.P.505 FIFTH AVE., 17TH FLOORInvestments, L.L.L.P.  StepStone-SYNNEW YORKInvestments, L.L.L.P.  StepStone-SYNNEW YORKRubin  StevenMiamiRubin  StevenMiamiDavis  StewartMiamiSV Life Sciences Fund IV (GP), L.P.BOSTONSV LIFE SCIENCES FUND IV, L.P.BOSTONSV LIFE SCIENCES FUND IV STRATEGIC PARTNERS, L. P.BOSTONSVLSF IV, LLC10% Owner BOSTONSYNERGY LIFE SCIENCE PARTNERS L P10% Owner PORTOLA VALLEYSynergy Venture Partners, LLCPORTOLA VALLEYPope  ToddMiamiPope  ToddMorrisvilleUniMed Investment Inc.TAIPEIKevin  WayneDirector MIAMIKevin  WayneDirector MIAMIKevin  WayneDirector MIAMIKevin  WayneDirector MIAMIJr.  Starling  William,MorrisvilleKelley  WilliamMorrisvilleStarling, Jr.  WilliamMiamiPersons related to Mudit K.  Jain - iRhythm Technologies, Inc.NamePositionCityTiba  AynechiSAN FRANCISCOBruce G.  BodakenDirector SAN MATEOde Clercq  CasperSan Franciscode Clercq  CasperSan FranciscoPHILIPPE  CHAMBONSUNNYVALEGrant  ChrisSan FranciscoJeffrey  CrowePALO ALTOClercq Casper L.  deDirector PALO ALTOJeani  DelagardelleMENLO PARKMatthew C.  GarrettChief Financial Officer SAN FRANCISCOPROMOD  HAQUEMead  HardwinSan FranciscoMatthew D.  HowardPALO ALTORONALD  HUNTNEW YORKMudit K.  JainPORTOLA VALLEYGreen  JoshuaSan FranciscoGreen  JoshuaSan FranciscoLenane  JudithSan FranciscoKing  KevinSan FranciscoKing  KevinSan FranciscoKevin M  KingPresident and CEO SANTA CLARAVijay K  LathiDirector MENLO PARKGarrett  MatthewSan FranciscoGoldberg  MichaelSan FranciscoGoldberg  MichaelMenlo ParkNew Leaf Venture Associates II, L.P.NEW YORKNew Leaf Venture Management II, L.L.C.NEW YORKNew Leaf Ventures II, L.P.10% Owner NEW YORKNorwest Venture Partners XI, LP10% Owner MINNEAPOLISNorwest Venture Partners XII, LPPALO ALTOA/S  Novo10% Owner BAGSVAERDHardwin  Mead  R.San FranciscoMead  R.San FranciscoLiam  RatcliffeNEW YORKScott  RaymondSan FranciscoKatz  RobertaSan FranciscoKatz  RobertaSan FranciscoKatz  RobertaSan FranciscoMARK J  RUBASHDirector SAN JOSEBrasch  SamSan FranciscoBrasch  SamSan FranciscoRaymond W.  ScottDirector SAN FRANCISCOGuyer  ShellySan FranciscoGuyer  ShellySan FranciscoRALPH  SNYDERMANDirector Richard S.  StackPORTOLA VALLEYWilliam N  Starling JRPOCATELLOJohnson  SteveSan FranciscoDerrick  SungSee Remarks SAN FRANCISCOSYNERGY LIFE SCIENCE PARTNERS L P10% Owner PORTOLA VALLEYSynergy Venture Partners, LLCPORTOLA VALLEYABHIJIT Y  TALWALKARDirector SANTA CLARAAynechi  TibaSan FranciscoKumar  UdaySan FranciscoKumar  UdaySan FranciscoLathi  VijaySan FranciscoLathi  VijaySan FranciscoDavid A  VortEVP, Sales SAN FRANCISCOWillis  WilliamSan FranciscoStarling  WilliamSan FranciscoStarling  WilliamSan FranciscoStarling  WilliamPortola ValleyWillis  WilliamSan Francisco












 








Mudit Jain, Ph.D.
















Mudit Jain, Ph.D.









Dr. Mudit Jain has more than a decade of operational experience in various functional roles including research, product development, business development, M&A, and venture capital. Most recently, Mudit was an Executive Director with Johnson and Johnson Development Corporation as part of their Management team and led the firms medical device investments in the Midwest and East Coast and had Board responsibilities for JJDC investments. Prior to JJDC, Mudit was a Corporate Director with Corporate Office of Science and Technology at JNJ, where he worked with JNJs Chief Scientific Officer and was instrumental in evaluating and assessing early stage growth opportunities for the medical device franchises across JNJ. Prior to JNJ Mudit was with Guidant Corporations Cardiac Rhythm Management Division and led their efforts to develop and evaluate new medical device technologies in cardiac ablation, heart failure, and regenerative therapies.  Mudit has also worked as a consultant to Epicor, Inc.(part of St. Jude Medical), Cardiac Pathways Corporation (acquired by Boston Scientific), and Medtronic.  Mudit holds seven issued patents and has published numerous articles in peer reviewed publications.  Mudit currently serves as a member on the Board of Directors of Inspire Medical Systems and is a Board Observer for Oraya Therapeutics. 

Mudit graduated with a B.E. in Electrical Engineering from Regional Engineering College, Nagpur, India, where he ranked first in his class. He received his Ph.D. from Duke University in Biomedical Engineering. His was the first Ph.D. awarded in cardiac radiofrequency ablation in the nation. Mudit completed his M.B.A. from the Wharton School focusing on Healthcare Management and Finance and was named on the Directors list for academic achievement.
















